Latest Breaking News On - International advocacy head - Page 1 : comparemela.com

Bharat Biotech reaches out to FDA for phase 3 clinical trials of COVAXIN in US Bharat Biotech reaches out to FDA for phase 3 clinical trials of COVAXIN in US According to Dr. Raches Ella, Bharat Biotech s Business Development and International Advocacy Head said that the COVAXIN is expected to be approved by the WHO by the end of the third or fourth quarter of 2021. Covaxin According to Dr. Raches Ella, Bharat Biotech’s Business Development and International Advocacy Head said that the COVAXIN is expected to be approved by the WHO by the end of the third or fourth quarter of 2021. Ninety per cent of the documents required for Emergency Use Listing of  Covaxin have been submitted to the WHO and the remaining are expected to be filed in June. The company is confident about getting the approval from the international body. 

Raches ellaBharat biotech business developmentInternational advocacy headWorld health organizationDrug administrationBharat biotechBusiness developmentEmergency use listingForeign secretary harsh shringlaBharat biotechs business development and international advocacஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்பாரத் பயோடெக்வணிக வளர்ச்சிஅவசரம் பயன்பாடு பட்டியல்